1-9 of 9
Jennifer Vaughn
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and safety of the LSD1 inhibitor bomedemstat in participants with polycythemia vera (PV) resistant or intolerant to cytoreductive therapy: The Phase 2 shorespan-004 study

Free
Lindsay Rein, Alice Livings, Rebecca Frewin, Andrew Innes, Ali Mahdi, Ciro Rinaldi, Natalia Curto-Garcia, Jennifer Vaughn, Joseph Shatzel, Paul Yeh, Jessica Flynn, Jonas Jutzi, Patricia Marinello, Michael Leahy
Journal: Blood
Blood (2025) 146 (Supplement 1): 83.
https://doi.org/10.1182/blood-2025-83
Published: 2025
Journal Articles

Efficacy and safety results from the primary analysis of the pivotal summit trial: Bezuclastinib in adults with non-advanced systemic mastocytosis

Free
Lindsay Rein, Nathan Boggs, Prithviraj Bose, Brian Modena, Vito Sabato, Karin Hartmann, Cem Akin, Tracy George, Cecilia Arana Yi, Hanneke Oude Elberink, Deepti Radia, Andreas Reiter, Miguel Piris-Villaespesa, Ingunn Dybedal, Jens Panse, Stephen Oh, Pankit Vachhani, Anthony Hunter, Mariana Castells, Cristina Bulai Livideanu, Paul van Daele, Arnold Kirshenbaum, Ivan Alvarez-Twose, Jennifer Vaughn, Minakshi Taparia, Sonia Cerquozzi, Andrzej Mital, Marek Hus, ALESSANDRA ROMANO, John Fahrenholz, Frederick Lansigan, Cristina Papayannidis, Helena Pomares, Michela Rondoni, Celalettin Ustun, Richard Herrscher, Michael Manning, Stéphane Barete, Mar Guilarte, Candido Rivera, Jonathan Bernstein, Peter Vadas, Chiara Elena, Derek McCulloch, Nina Orfali, Clodagh Keohane, Francesco Mannelli, Philippe Schafhausen, Amanda Pilla, Jenna Zhang, Lei Sun, Nisha Shah, Hina Jolin, Rachael Easton, Jessica Sachs, Frank Siebenhaar, Daniel Deangelo
Journal: Blood
Blood (2025) 146 (Supplement 1): 80.
https://doi.org/10.1182/blood-2025-80
Published: 2025
Journal Articles

A diagnostic hematology clinic pilot program: Increasing access and optimizing resources

Free
Kathryn Knisely, Marina Beltrami Moreira, Roberta Azbell, Lindsay Hunter, Christine Harsh, Tina Sowers, Raquel Reinbolt, Samantha Knight, Rupa Ghosh-Berkebile, Victoria Krogg, Spero Cataland, Regina Crawford, Sherraine Della-Moretta, Nicolas Gallastegui-Crestani, Jennifer Vaughn
Journal: Blood
Blood (2025) 146 (Supplement 1): 597.
https://doi.org/10.1182/blood-2025-597
Published: 2025
Journal Articles

Treatment cost per AE symptom-free day of asciminib and second-generation tyrosine kinase inhibitors in newly diagnosed patients with chronic myeloid leukemia

Free
Jennifer Vaughn, Nadine Zawadzki, Caroline Hardy, Gabriel Marquez, Gopi Madhav Bommidi, Poornima Sachin Dhobe, Sai Vasmi Gedala, Islam Mohamad Sadek, Jason Shafrin, David Wei
Journal: Blood
Blood (2025) 146 (Supplement 1): 2835.
https://doi.org/10.1182/blood-2025-2835
Published: 2025
Journal Articles

A phase 2, open-label study of the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of DISC-3405 in participants with polycythemia vera (PV)

Free
Naseema Gangat, Ayalew Tefferi, Aaron Gerds, Michael Grunwald, Anna Halpern, Laura Michaelis, Stephen Oh, Caitlin O'Neill, Jeanne Palmer, Kristen Pettit, Lindsay Rein, Candido Rivera, Gary Schiller, Joseph Shatzel, Lisa Guiducci, Jennifer Vaughn, Anne Wofford, Marcus Carden, Will Savage, Prithviraj Bose, Naveen Pemmaraju
Journal: Blood
Blood (2025) 146 (Supplement 1): 2053.
https://doi.org/10.1182/blood-2025-2053
Published: 2025
Journal Articles

Comparative impact of tyrosine kinase inhibitor dose-reduction on ability to achieve treatment-free remission among TKI-intolerant patients with chronic myeloid leukemia

Free
Melanie Rebechi, Nidhi Sharma, Audrey Propp, Qiuhong Zhao, Michael Marcucci, Allyson Waller, Marvellous Olowookere, Alyssa Swank, Christian Hu, Alice Mims, Jennifer Vaughn
Journal: Blood
Blood (2025) 146 (Supplement 1): 2004.
https://doi.org/10.1182/blood-2025-2004
Published: 2025
Journal Articles

Improved long-term tolerability with asciminib (ASC) vs investigator-selected (IS) tyrosine kinase inhibitors (TKIs) in patients (pts) with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP): Week 96 exploratory analysis of the phase 3 ASC4FIRST trial

Free
Timothy Hughes, Jorge Cortes, Jennifer Vaughn, Kathryn Flynn, Naoto Takahashi, Ghayas Issa, Felice Bombaci, Jianxiang Wang, Dong-Wook Kim, Dennis Kim, Jiri Mayer, Yeow Tee Goh, Philipp le Coutre, Inho Kim, Gabriel Etienne, Rajendra Jinwal, Andrea Damon, David Wei, Gabriel Marquez, Ennan Gu, Gopi Madhav Bommidi, Andreas Hochhaus, Richard Larson
Journal: Blood
Blood (2025) 146 (Supplement 1): 5549.
https://doi.org/10.1182/blood-2025-5549
Published: 2025
Journal Articles

Ruxolitinib and interferon alfa induce superior rates of complete peripheral blood count remission compared to anagrelide in hydroxyurea-exposed essential thrombocythemia

Free
Tripura Vithala, Seungyeon Lee, Haley Roberts, Shivani Handa, Jennifer Vaughn, Sarah Wall, Ping Zhang, Andrew Srisuwananukorn
Journal: Blood
Blood (2025) 146 (Supplement 1): 3824.
https://doi.org/10.1182/blood-2025-3824
Published: 2025
Journal Articles

Treatment of Recurrent or Persistent AML/MDS After Allogeneic Hematopoietic Cell Transplantation with Azacitidine.

Free
Jennifer Vaughn, MD, MSPH, Barry Storer, PhD, Marco Mielcarek, MD, Edus H. Warren, III, MD, PhD, Paul J. Martin, MD, Brenda M. Sandmaier, MD, Elihu H. Estey, MD, Rainer Storb, MD, H. Joachim Deeg, MD, Bart Lee Scott, MD
Journal: Blood
Blood (2010) 116 (21): 1288.
https://doi.org/10.1182/blood.V116.21.1288.1288
Published: 2010